592 related articles for article (PubMed ID: 27853989)
21. Impairment of astrocytic glutaminolysis in glutaric aciduria type I.
Komatsuzaki S; Ediga RD; Okun JG; Kölker S; Sauer SW
J Inherit Metab Dis; 2018 Jan; 41(1):91-99. PubMed ID: 29098534
[TBL] [Abstract][Full Text] [Related]
22. Glutaric acidemia type 1: outcomes before and after expanded newborn screening.
Viau K; Ernst SL; Vanzo RJ; Botto LD; Pasquali M; Longo N
Mol Genet Metab; 2012 Aug; 106(4):430-8. PubMed ID: 22728054
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis, treatment and outcome of glutaric aciduria type I in Zhejiang Province, China.
Yang L; Yin H; Yang R; Huang X
Med Sci Monit; 2011 Jul; 17(7):PH55-9. PubMed ID: 21709643
[TBL] [Abstract][Full Text] [Related]
24. (1)H-MRS in glutaric aciduria type 1: impact of biochemical phenotype and age on the cerebral accumulation of neurotoxic metabolites.
Harting I; Boy N; Heringer J; Seitz A; Bendszus M; Pouwels PJ; Kölker S
J Inherit Metab Dis; 2015 Sep; 38(5):829-38. PubMed ID: 25860816
[TBL] [Abstract][Full Text] [Related]
25. The long-term treatment of a patient with type 1 diabetes mellitus and glutaric aciduria type 1: the effect of insulin.
Del Rizzo M; Galderisi A; Celato A; Furlan F; Giordano L; Cazzorla C; Fasan I; Moretti C; Zschocke J; Burlina AB
Eur J Pediatr; 2016 Aug; 175(8):1123-8. PubMed ID: 26847429
[TBL] [Abstract][Full Text] [Related]
26. [Development of brain atrophy, therapy and therapy monitoring in glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency)].
Lawrenz-Wolf B; Herberg KP; Hoffmann GF; Hunneman DH; Lehnert W; Hanefeld F
Klin Padiatr; 1993; 205(1):23-9. PubMed ID: 8445849
[TBL] [Abstract][Full Text] [Related]
27. [Glutaric aciduria type I: an organic acidemia without acidosis with severe movement disorders].
Prats Viñas J
Neurologia; 2001 Oct; 16(8):337-41. PubMed ID: 11738010
[No Abstract] [Full Text] [Related]
28. Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I.
Harting I; Neumaier-Probst E; Seitz A; Maier EM; Assmann B; Baric I; Troncoso M; Mühlhausen C; Zschocke J; Boy NP; Hoffmann GF; Garbade SF; Kölker S
Brain; 2009 Jul; 132(Pt 7):1764-82. PubMed ID: 19433437
[TBL] [Abstract][Full Text] [Related]
29. Marked reduction of Na(+), K(+)-ATPase and creatine kinase activities induced by acute lysine administration in glutaryl-CoA dehydrogenase deficient mice.
Amaral AU; Cecatto C; Seminotti B; Zanatta Â; Fernandes CG; Busanello EN; Braga LM; Ribeiro CA; de Souza DO; Woontner M; Koeller DM; Goodman S; Wajner M
Mol Genet Metab; 2012 Sep; 107(1-2):81-6. PubMed ID: 22578804
[TBL] [Abstract][Full Text] [Related]
30. Neonatal screening for glutaric aciduria type I: strategies to proceed.
Lindner M; Ho S; Fang-Hoffmann J; Hoffmann GF; Kölker S
J Inherit Metab Dis; 2006; 29(2-3):378-82. PubMed ID: 16763905
[TBL] [Abstract][Full Text] [Related]
31. [Clinical and laboratory studies on 28 patients with glutaric aciduria type 1].
Wang Q; Ding Y; Liu Y; Li X; Wu T; Song J; Wang Y; Yang Y
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):415-9. PubMed ID: 25190159
[TBL] [Abstract][Full Text] [Related]
32. Selective Screening of Fatty Acids Oxidation Defects and Organic Acidemias by Liquid Chromatography/tandem Mass Spectrometry Acylcarnitine Analysis in Brazilian Patients.
Vargas CR; Ribas GS; da Silva JM; Sitta A; Deon M; de Moura Coelho D; Wajner M
Arch Med Res; 2018 Apr; 49(3):205-212. PubMed ID: 30119976
[TBL] [Abstract][Full Text] [Related]
33. The M405V allele of the glutaryl-CoA dehydrogenase gene is an important marker for glutaric aciduria type I (GA-I) low excretors.
Schillaci LA; Greene CL; Strovel E; Rispoli-Joines J; Spector E; Woontner M; Scharer G; Enns GM; Gallagher R; Zinn AB; McCandless SE; Hoppel CL; Goodman SI; Bedoyan JK
Mol Genet Metab; 2016 Sep; 119(1-2):50-6. PubMed ID: 27397597
[TBL] [Abstract][Full Text] [Related]
34. [Progress of glutaric aciduria type I].
Gao JZ; Luo XP
Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):912-4. PubMed ID: 23324148
[No Abstract] [Full Text] [Related]
35. Glutaric acidemia type 1: Treatment and outcome of 168 patients over three decades.
Strauss KA; Williams KB; Carson VJ; Poskitt L; Bowser LE; Young M; Robinson DL; Hendrickson C; Beiler K; Taylor CM; Haas-Givler B; Hailey J; Chopko S; Puffenberger EG; Brigatti KW; Miller F; Morton DH
Mol Genet Metab; 2020 Nov; 131(3):325-340. PubMed ID: 33069577
[TBL] [Abstract][Full Text] [Related]
36. [Complex heterogeneity phenotypes and genotypes of glutaric aciduria type 1].
Wang Q; Yang YL
Zhongguo Dang Dai Er Ke Za Zhi; 2016 May; 18(5):460-5. PubMed ID: 27165598
[TBL] [Abstract][Full Text] [Related]
37. An explanation for metabolite excretion in high- and low-excretor patients with glutaric acidemia type 1.
Goodman SI; Woontner M
Mol Genet Metab; 2019 Aug; 127(4):325-326. PubMed ID: 31324527
[No Abstract] [Full Text] [Related]
38. Impairment of GABAergic system contributes to epileptogenesis in glutaric acidemia type I.
Vendramin Pasquetti M; Meier L; Loureiro S; Ganzella M; Junges B; Barbieri Caus L; Umpierrez Amaral A; Koeller DM; Goodman S; Woontner M; Gomes de Souza DO; Wajner M; Calcagnotto ME
Epilepsia; 2017 Oct; 58(10):1771-1781. PubMed ID: 28762469
[TBL] [Abstract][Full Text] [Related]
39. Rare presentation of a treatable disorder: glutaric aciduria type 1.
Badve MS; Bhuta S; Mcgill J
N Z Med J; 2015 Feb; 128(1409):61-4. PubMed ID: 25721963
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
